That could be an advantage to LL to be compared to
Post# of 148281
(Total Views: 520)
Posted On: 10/22/2020 8:57:49 PM
That could be an advantage to LL to be compared to remdeisivir in future double-blind placebo trials. What a disgusting piece of shit news to come home to - inferior BP drug approved before CytoDyn's better treatment. Welcome to life in a third-world shithole run by a tinpot dicktater. F'nda whores doin' the trump rally dance.
(5)
(4)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼